CD248 expression was positively related to tumor mutation burden (TMB) in LGG (P = 0.0043), while negatively related to TMB in KIRP (P = 0.0009) and CHOL (P = 0.0028) (Figure 9A; Supplementary Table S4). This evidence concerns the gene CD248 and neoplasm.